Human Asprosin
Origin: | Recombinant | Cat. No.: | 41460 |
Tag: | N-terminal 6xHis | Size: | 0.1 mg |
Source: | E.coli | Purity: | >95% |
Other Names: |
| Species: | Human |
INTRODUCTION
Asprosin is a fasting-induced glucogenic protein that responds to low dietary glucose by stimulating hepatic glucose release. It is secreted by white adipose tissue and circulates in the plasma at nanomolar levels. Asprosin- induced hepatic glucose production is mediated by G protein-cAMP-protein kinase A pathway and is shown to be pathologically related with human and mouse insulin resistance.
DESCRIPTION
Expressed in E.coli with total 176 AA. Mw: 20.0 KDa (calculated).
N-terminal 6xHis-tag and EK cleavage site, 36 extra AA (highlighted).
Recombinant antigen for research use or manufacturing only.
AMINO ACID SEQUENCE
MRGSHHHHHHGMASMTGGQQMGRDLYDDDDKDRWGSSTNETDASNIEDQSETEANVSLASWDVEKTAIFAFNISHVSNKVRILELLPALTTLTNHNRYLIESGNEDGFFKINQKEGISYLHFTKKKPVAGTYSLQISSTPLYKKKELNQLEDKYDKDYLSGELGDNLKMKIQVLLH
STORAGE
Store lyophilized protein at –20°C. Aliquot reconstituted protein and store at –80°C. Avoid repeated freezing/thawing cycles.
RECONSTITUTION
Add deionized water to prepare a working stock solution of approximately 1 mg/mL and let thelyophilized pellet dissolves completely.
QUALITY CONTROL TEST
BCA to determine quantity of the protein.
SDS PAGE to determine purity of the protein.
FORMULATION
Lyophilized at 1 mg/mL in NaCl 500mM, KCl 2.7mM, Na2HPO4 10mM, KH2PO4 1.8mM, pH 8.0.
APPLICATION
ELISA and Western Blotting.
ENDOTOXIN LEVEL
<0.2 EU/ug